Indian peptide therapeutics market is anticipated to project a CAGR of 7.6%, during the forecast period. India is one of the potential markets for peptide therapeutics particularly due to a high prevalence of cancer and large mortality due to cancer and CVDs. According to the National Institute of Cancer Prevention and Research, India recorded 2.25 […]
